Rena Conti

University of Chicago

SCHOLARLY PAPERS

9

DOWNLOADS

223

SSRN CITATIONS
Rank 26,886

SSRN RANKINGS

Top 26,886

in Total Papers Citations

16

CROSSREF CITATIONS

17

Scholarly Papers (9)

Actions:
Email selected abstracts
1.

Pricing in the Market for Anticancer Drugs

NBER Working Paper No. w20867
Number of pages: 34 Posted: 20 Jan 2015
David H. Howard, Peter Bach, Ernst R. Berndt and Rena Conti
Emory University - Department of Health Policy and Management, Memorial Sloan Kettering Cancer Center - Department of Medicine, Massachusetts Institute of Technology (MIT) - Sloan School of Management and University of Chicago
Downloads 58 (418,219)
Citation 8

Abstract:

Loading...

2.

Specialty Drug Prices and Utilization after Loss of U.S. Patent Exclusivity, 2001-2007

NBER Working Paper No. w20016
Number of pages: 48 Posted: 31 Mar 2014 Last Revised: 30 Sep 2014
Rena Conti and Ernst R. Berndt
University of Chicago and Massachusetts Institute of Technology (MIT) - Sloan School of Management
Downloads 51 (443,400)
Citation 2

Abstract:

Loading...

3.

The Landscape of Us Generic Prescription Drug Markets, 2004-2016

NBER Working Paper No. w23640
Number of pages: 64 Posted: 04 Aug 2017 Last Revised: 04 Feb 2021
Ernst R. Berndt, Rena Conti and Stephen Murphy
Massachusetts Institute of Technology (MIT) - Sloan School of Management, University of Chicago and Massachusetts Institute of Technology (MIT)
Downloads 31 (532,800)
Citation 2

Abstract:

Loading...

4.

The Geography of Prescription Pharmaceuticals Supplied to the U.S.: Levels, Trends and Implications

NBER Working Paper No. w26524
Number of pages: 53 Posted: 09 Dec 2019
Neriman Beste Kaygisiz, Yashna Shivdasani, Rena Conti and Ernst R. Berndt
Wellesley College, Wellesley College, University of Chicago and Massachusetts Institute of Technology (MIT) - Sloan School of Management
Downloads 22 (587,055)

Abstract:

Loading...

5.

Four Facts Concerning Competition in U.S. Generic Prescription Drug Markets

NBER Working Paper No. w26194
Number of pages: 44 Posted: 18 Sep 2019 Last Revised: 24 Sep 2019
Rena Conti and Ernst R. Berndt
University of Chicago and Massachusetts Institute of Technology (MIT) - Sloan School of Management
Downloads 22 (587,055)
Citation 1

Abstract:

Loading...

6.

The Generic Drug User Fee Amendments: an Economic Perspective

NBER Working Paper No. w23642
Number of pages: 59 Posted: 11 Aug 2017 Last Revised: 06 Feb 2021
Ernst R. Berndt, Rena Conti and Stephen Murphy
Massachusetts Institute of Technology (MIT) - Sloan School of Management, University of Chicago and Massachusetts Institute of Technology (MIT)
Downloads 21 (593,670)
Citation 4

Abstract:

Loading...

7.

The Effect of Fda Advisories on Branded Pharmaceutical Firms' Valuations and Promotion Efforts

NBER Working Paper No. w17528
Number of pages: 27 Posted: 22 Oct 2011 Last Revised: 28 Jul 2013
Rena Conti, Haiden Huskamp and Ernst R. Berndt
University of Chicago, affiliation not provided to SSRN and Massachusetts Institute of Technology (MIT) - Sloan School of Management
Downloads 14 (641,522)

Abstract:

Loading...

8.

NBER Working Paper No. w26512
Number of pages: 42 Posted: 03 Dec 2019 Last Revised: 15 Jun 2020
Paolo Adajar, Ernst R. Berndt and Rena Conti
Massachusetts Institute of Technology (MIT) - Department of Economics, Massachusetts Institute of Technology (MIT) - Sloan School of Management and University of Chicago
Downloads 3 (722,429)
  • Add to Cart

Abstract:

Loading...

9.

Valuing Rare Pediatric Drugs: An Economics Perspective

NBER Working Paper No. w27978
Number of pages: 31 Posted: 27 Oct 2020
Rena Conti, Jonathan Gruber, Daniel Ollendorf and Peter Neumann
University of Chicago, Massachusetts Institute of Technology (MIT) - Department of Economics, affiliation not provided to SSRN and Tufts New England Medical Center (NEMC)
Downloads 1 (744,079)
  • Add to Cart

Abstract:

Loading...